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The Journal of Immunology
Monocyte Adhesion, Migration, and Extracellular Matrix
Breakdown Are Regulated by Integrin aVb3 in Mycobacterium
tuberculosis Infection
Sara Brilha,*,† Riccardo Wysoczanski,*,‡ Ashley M. Whittington,* Jon S. Friedland,*,1 and
Joanna C. Porter†,1
In tuberculosis (TB), the innate inflammatory immune response drives tissue destruction, morbidity, and mortality. Monocytes
secrete matrix metalloproteinases (MMPs), which have key roles in local tissue destruction and cavitation. We hypothesized that
integrin signaling might regulate monocyte MMP secretion in pulmonary TB during cell adhesion to the extracellular matrix
(ECM). Adhesion to type I collagen and fibronectin by Mycobacterium tuberculosis–stimulated monocytes increased MMP-1 gene
expression by 2.6-fold and 4.3-fold respectively, and secretion by 60% (from 1208.1 6 186 to 1934.4 6 135 pg/ml; p < 0.0001) and
63% (1970.3 6 95 pg/ml; p < 0.001). MMP-10 secretion increased by 90% with binding to type I collagen and 55% with
fibronectin, whereas MMP-7 increased 57% with collagen. The ECM did not affect the secretion of tissue inhibitors of
metalloproteinases-1 or -2. Integrin aVb3 surface expression was specifically upregulated in stimulated monocytes and was
further increased after adhesion to type I collagen. Binding of either b3 or aV integrin subunits increased MMP-1/10 secretion
in M. tuberculosis–stimulated monocytes. In a cohort of TB patients, significantly increased integrin b3 mRNA accumulation in
induced sputum was detected, to our knowledge, for the first time, compared with control subjects (p < 0.05). Integrin aVb3
colocalized with areas of increased and functionally active MMP-1 on infected monocytes, and aVb3 blockade markedly de-
creased type I collagen breakdown, and impaired both monocyte adhesion and leukocyte migration in a transwell system (p <
0.0001). In summary, our data demonstrate that M. tuberculosis stimulation upregulates integrin aVb3 expression on monocytes,
which upregulates secretion of MMP-1 and -10 on adhesion to the ECM. This leads to increased monocyte recruitment and
collagenase activity, which will drive inflammatory tissue damage. The Journal of Immunology, 2017, 199: 000–000.
T
uberculosis (TB) remains an important global health
problem with 8.6 million new cases annually, of which at
least 480,000 are multidrug resistant (1). Lung cavitation
is the hallmark of TB and results from extracellular matrix (ECM)
destruction, creating an immuno-privileged site within which
mycobacteria can proliferate and spread to new hosts. In addition,
tissue damage impairs organ function and results in patient mor-
bidity and mortality. Pulmonary ECM is composed of a network
of molecules including type I, III, and IV collagen, fibronectin,
laminin, elastin, and proteoglycans. Type I collagen is the primary
structural fibril of the lung and is highly resistant to enzymatic
degradation. In addition to its biomechanical properties, type I
collagen has important roles in cell survival, adhesion, prolif-
eration, and migration (2). Fibronectin is present in lower
amounts and has important functions in cell adhesion, growth,
and migration (3).
Human monocytes are a key element in the formation of TB
granuloma, which is the main cellular host response to infection.
Integrins are a family of receptors involved in regulation of immune
responses (4), and peripheral blood monocytes express eight
integrin heterodimers: a1b1, a3b1, a4b1, a5b1, aXb2, aMb2,
aLb2, and aVb3 (4, 5). These are key in interactions with other
cells and with the ECM. Monocyte recruitment in acute inflam-
mation is mediated in part by b2-integrin receptors (6, 7) whereas
integrin a4b1 promotes arrest and adhesion to VCAM-1 (8).
Engagement of b2-integrins is also involved in downregulation of
NF-kB–dependent genes encoding for proinflammatory cytokines
via inhibition of TLR signaling (9). Integrin avb3 modulates
aLb2 integrin–dependent monocyte adhesion to ICAM-1 (10).
Mycobacterium tuberculosis infection of macrophages was reported
to increase cellular adhesion and decrease surface expression of the
phagocytic complement receptors (CR) 3 (integrin aMb2) and CR4
(integrin aXb2) (11).
Matrix metalloproteinases (MMPs) are zinc-containing endo-
peptidases with diverse functions in inflammation and tissue repair.
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Most MMPs are able to degrade components of the pulmonary
ECM, and some are released during the innate inflammatory im-
mune response to M. tuberculosis infection. Our group has shown
that MMPs are expressed within TB granulomas (12–14) and
associated with disease severity (15) and tissue damage (16–18).
MMP-1 is the main collagenase responsible for tissue destruction
in pulmonary TB (19). In TB patients, including those with TB/
HIV coinfection, elevated plasma MMP-1 concentrations were
associated with collagen breakdown (20).
In TB, extensive tissue destruction may occur even with a low
bacterial load, indicating a role of immune intercellular networks
that drive MMP secretion. MMP expression is initially upregu-
lated by M. tuberculosis–infected monocytes and macrophages,
which then recruit peripheral blood monocytes by secretion of
cytokines and chemokine, amplifying this response. MMP-
dependent tissue destruction is, therefore, driven by activated
uninfected neighboring cells, such as monocytes or respiratory
epithelial cells, due to signaling networks within the granuloma
(21, 22). MMP-1 is activated from a precursor zymogen (pro–
MMP-1), a process which can be promoted by other MMPs, such
as the stromelysins MMP-3 and -10 (23, 24). MMP-1 is inhibited
by the tissue inhibitors of metalloproteinases (TIMP)-1 and -2
(25–27).
Although integrins are required for adhesion and cellular re-
sponse to cues from the ECM environment, it is not known
whether integrin-dependent adhesion to the lung ECM plays a
role in the regulation of MMP gene expression and secretion by
human monocytes recruited to the lung in TB. In the current study,
we investigated whether contact with ECM components affects
the M. tuberculosis–associated MMP gene expression and se-
cretion from monocytes and dissected the mechanisms by which
integrin signaling regulates MMP secretion in M. tuberculosis
infection.
Materials and Methods
Abs
To study integrin regulation of MMP expression, primary mouse anti-
human integrin b1 (clone P4C10), integrin b2 (clone MEM48), integ-
rin b3 (clone B3A), FITC-conjugated anti-human integrin b1, and
integrin aV (clone 272-17E6) Abs were used (all from Millipore,
Hertfordshire, U.K.). FITC-conjugated goat anti-mouse IgG1 (Sigma-
Aldrich, Dorset, U.K.), and Cy5 conjugated goat anti-rabbit (Abcam,
Cambridge, U.K.) were used as secondary Abs. Mouse IgG1 and FITC-
conjugated mouse IgG1 were the isotype controls (BD Diagnostics,
Oxford, U.K.).
M. tuberculosis H37RV culture
M. tuberculosis strain H37Rv was cultured in Middlebrook 7H9 medium
supplemented with 10% ADC enrichment medium (BD Diagnostics),
0.2% glycerol, and 0.02% Tween 80 (Sigma-Aldrich) with agitation at 10
rpm. For infection experiments, mycobacteria were used at midlogarithmic
growth at an OD of 0.60 (Biowave Cell Density Meter; WPA, Cambridge,
U.K.).
Primary monocyte isolation and culture
Ethical approval for obtaining healthy human volunteer blood was provided
by the OuterWest London Research Ethics Committee and written informed
consent was obtained from individuals. PBMCs were isolated by gradient
density centrifugation with Ficoll-Paque PLUS (GE Healthcare, Buck-
inghamshire, U.K.) and CD16 monocytes were purified by negative MACS
(MACS monocyte isolation kit II; Miltenyi Biotec, Surrey, U.K.) according
to the manufacturer’s instructions. Purity was confirmed by CD64 staining
and FACS analysis and was $95%. Viability assessed by trypan blue
exclusion was $98%.
Monocytes were seeded at a density of 2.5 3 105 cells per cm2 in RPMI
1640 supplemented with 2 mM glutamine, 10 mg/ml ampicillin, and 10%
heat-inactivated FBS. Monocytes were allowed to rest for 1 h before
adding 1:5 diluted conditioned medium from M. tuberculosis–infected
monocytes (CoMtb) or conditioned medium from uninfected monocytes
(CoMCont), or infecting with M. tuberculosis H37Rv at a multiplicity of
infection (MOI) = 1. Monocytes were incubated for 24 h and supernatants
were collected for protein concentrations, whereas for investigation of
gene expression, monocytes were incubated for 6 h, rinsed with sterile
PBS, and lysed with Tri-Reagent.
CoMtb
Preparation of CoMtb was performed as previously described (28). Briefly,
human monocytes cultured in RPMI 1640 (Life Technologies, Paisley,
U.K.) medium supplemented with 2 mM glutamine and 10 mg/ml ampi-
cillin, were infected withM. tuberculosis strain H37Rv at an MOI of 1, and
incubated for 24 h at 37˚C and 5% CO2. Supernatants were sterile filtered
and aliquots stored at 220˚C. CoMCont and CoMtb used in each exper-
iment were donor matched.
Coating of tissue culture plates with ECM components or
integrin Abs
Tissue culture plates were precoated with 100 mg/ml native type I collagen
from human fibroblasts (VitroCol), 250 mg/ml type IV collagen from hu-
man placenta, or 20 mg/ml human plasma fibronectin (all from Advanced
BioMatrix, Carlsbad, CA). In brief, for type I collagen, wells were coated
at a desired concentration of VitroCol diluted in sterile distilled water and
incubated at room temperature for 1 h, rinsed with sterile PBS or HBSS.
Type IV collagen was diluted in a 0.25% acetic acid solution and coated
plates incubated for 1 h and rinsed with HBSS. Fibronectin was diluted in
HBSS, plates incubated for 1 h, and rinsed with sterile distilled water.
After incubation, any excess material was aspirated and plates were
blocked with sterile 2% heat-denatured BSA, rinsed with PBS or HBSS,
and allowed to air dry for at least 45 min.
To find the optimal concentration of ECM ligands, initial titration was
performed using the human monocyte cell line THP-1 (Supplemental Fig.
1A–C). Briefly, 96-well plates were coated with increasing concentra-
tions of type I collagen (0, 1, 10, 100, and 200 mg/ml), type IV collagen
(0, 10, 100, 250, and 300 mg/ml) and fibronectin (0, 0.2, 2, 20, and 40
mg/ml), and blocked with 2% heat-denatured BSA to prevent unspecific
adhesion. Control wells without ECM were only blocked with BSA.
THP-1 monocytes were prelabeled with 5 mM calcein, and integrin
aMb2 (Mac-1) was blocked with 10 mg/ml anti-aM Ab (clone LPM19C)
to prevent binding to BSA. Then 5 3 104 labeled monocytes were added
per well in RPMI 1640 without phenol red, activated with 20 nM PMA,
and let to adhere for 1.5 h. A standard curve was generated from serial
dilutions of a known concentration of monocytes, and fluorescence
measured in a FLUOstar Omega microplate reader (BMG Labtech,
Buckinghamshire, U.K.).
To selectively analyze engagement of specific integrins, tissue culture
plates were coated with goat anti-mouse IgG H+L polyclonal Ab (Sigma-
Aldrich) overnight at 4˚C, washed with PBS, and coated for 2 h at room
temperature with 20 mg/ml of anti-integrin Abs (Millipore).
Measurement of MMP and TIMP concentrations
MMP and TIMP concentrations were analyzed by ELISA (Duoset; R&D
Systems, Abingdon, U.K.) or by Luminex bead array (Luminex 200; Bio-
Rad, Hertfordshire, U.K.) using the Fluorokine MAP kit (R&D Systems)
according to the manufacturer’s instructions. Lower limits of sensitivity for
the Duoset kits are: 21.2 pg/ml for TIMP-1, 31.2 pg/ml for TIMP-2, 156
pg/ml for MMP-1, and 31.2 pg/ml for MMP-10. In the Fluorokine
Luminex kit the lower limits are: 1.1 pg/ml for MMP-1, 12.6 pg/ml for
MMP-2, 7.3 pg/ml for MMP-3, 6.6 pg/ml for MMP-7, 13.7 pg/ml for
MMP-9, and 3.2 pg/ml for MMP-10. Variation on secreted concentrations
of MMPs and TIMP between individual donors is shown in Supplemental
datasets.
RNA extraction and real-time RT-PCR
Total RNAwas extracted from monocyte lysates using PureLink RNAMini
Kit (Life Technologies) according to the manufacturer’s instructions.
Quantitative real-time RT-PCR was performed using the OneStep RT-PCR
Master Mix (Qiagen, Crawley, U.K.) according to the manufacturer’s in-
struction on a Stratagene Mx3000P platform (SABiosciences, Crawley,
U.K.) using 15 mg of RNA per sample. To determine the quantitative change
in RNA, standard curves were prepared from a known concentration of the
genes of interest and subjected to real-time PCR as above. MMP-1 primers
and probes were custom made and supplied by Sigma-Aldrich (forward
primer: 59-AAGATGAAAGGTGGACCAACAATT-39; reverse primer: 59-
CCAAGAGAATGGCCGAGTTC-39; probe: 59-FAM-CAGAGAGTA-
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CAACTTACATCGTGTTGCGGCTC-TAMRA-39), and 18S rRNA primer
and probe mix was supplied by Life Technologies.
RNA extraction and real-time PCR from induced sputum
The study was approved by the University of Cape Town (HREC Ref 516/
2011), as previously described (29). Informed consent was obtained in all
cases. Later 1 ml of RNA (Qiagen) was added on site to the sputum
samples and mucolysis was performed by adding an equal volume of 0.1%
DTT (Sigma-Aldrich), and agitating gently at room temperature for 20
min. The mucoid layer was filtered through 100 mm pore-size strainer and
centrifuged at 500 3 g for 10 min. The cell pellet was aspirated and 1.5 ml
of cold TRI reagent added before vortexing. Total RNA was extracted
using the Purelink RNA Mini Kit (Life Technologies) and real-time RT-
PCR was performed using 15 ng RNA and the OneStep RT-PCR Kit (Qia-
gen) on a Stratagene Mx3000Pro, using integrin b3 and b-actin primers and
probes (Life Technologies). Analysis was performed using the Pfaffl com-
parative cycle threshold (Ct) method, applying the equation: ratio (integrin
b3:b-actin mRNA) = E b3
DCt(calibrator-sample)/E b2
actinDCt (calibrator-sample); E is
the real-time PCR efficiency of one cycle in the exponential phase, calcu-
lated according to the equation: E = 10[21/slope]. Samples without a Ct
value for integrin b3 after 43 cycles but with a Ct for b-actin were con-
sidered negative.
Flow cytometry
Monocytes were detached with 0.5 M EDTA (Life Technologies), washed
with PBS, fixed with cold 4% paraformaldehyde, and blocked with 1%
BSA/5% human serum buffer. Cells were incubated for 1 h at 4˚C with
primary mouse anti-human integrin Ab or mouse isotype IgG1 control
and FITC-conjugated anti-mouse secondary Ab. For M. tuberculosis–
infected monocytes, cells were labeled with the Abs first and fixed for 1 h
at 4˚C with 4% paraformaldehyde. Flow cytometry was performed on a
FACSCalibur cytometer that was calibrated using FACS CaliBRITE
beads (BD Biosciences). The baseline forward scatter, side scatter, and
FL1H settings were adjusted using an unstained, unstimulated monocyte
sample. Mean fluorescence intensities (MFI) were compared after nor-
malization to the isotype control. Data were analyzed using FlowJo
vX.0.6 (Tree Star, Ashland, OR). Analysis of integrin aVb3 in the
presence of ECM components in M. tuberculosis– or CoMtb-stimulated
monocytes was performed by plotting MFI data normalized to respective
control cells (with control media or CoMCont) from four different
healthy volunteers (n = 4).
Confocal microscopy
Eight-well glass slides were precoated type I collagen and monocytes
were seeded and incubated as described. Cells were fixed, blocked, and
stained with primary anti-integrin Abs and FITC-conjugated goat anti-
mouse secondary Ab. MMP-1 was stained with a mouse anti-human
MMP-1 primary Ab (Abcam) and Alexa Fluor 633 conjugated with
anti-mouse IgG (Life Technologies) as secondary Ab. Integrin b3 was
stained with a mouse anti-human b3 primary Ab and Alexa Fluor 488–
conjugated goat anti-mouse IgG secondary Ab. Staining with secondary
Ab alone was used as control. DQ collagen–coated slides were used to
analyze MMP collagenolytic activity by confocal microscopy. Integrin
b3 was blocked using 20 mg/ml functional blocking Ab, and a mouse
IgG1 Ab was used as a control. For all experiments DAPI was used as
nuclear counterstain. Phalloidin conjugated with Alexa Fluor 633 was
used to stain F-actin. Images were scanned on a Leica TCS SP5 con-
focal microscope equipped with 405 nm diode laser, 488 nm argon
laser, 543 nm and 633 nm HeNe lasers, and using the Leica Application
Suite 2.6.2 software (Milton Keynes, U.K.). Images were processed
using ImageJ software v1.46r (National Institutes of Health, Bethesda,
MD).
Transmigration assay
Briefly, 1 3 106 primary human monocytes were loaded on the apical
side of a transwell (5 mm pore) precoated with type I collagen. CoMtb or
CoMCont (1:2 dilution) was loaded on the basal side to act as a che-
motactic stimulus. Monocytes were let to migrate for 2 h at 37˚C, 5%
CO2. Migrating monocytes were collected from the basal side, centri-
fuged, and resuspended in 400 ml PBS, and 50 ml of CountBright Ab-
solute Counting Beads (Life technologies) were added to each tube.
Then 5.5 3 106 unstimulated monocytes were used to adjust baseline
forward scatter and side scatter, and exclude cell debris. The total
number of transmigrated monocytes was assessed by comparing the ratio
of bead to cell events.
Adhesion assay
Primary monocytes were stained for 40 min with 10 mMCellTracker Green
CMFDA (Life Technologies), washed, and incubated for 1 h with 20 mg/ml
mouse anti-human integrin b3, 20 mg/ml mouse IgG1 isotype control Abs,
or left untreated. Monocytes were loaded on 96-well plates precoated with
type I collagen and incubated with CoMCont or CoMtb for 18 h. Non-
adherent cells were removed by rising with PBS and serum-free RPMI
1640 without phenol red was loaded in the wells. Fluorescence was
measured in a FLUOstar Omega microplate reader.
Statistical analysis
Data analysis was performed using GraphPad Prism v5.02 (GraphPad soft-
ware, La Jolla, CA). Data are presented as mean 6 SD of three replicate
samples and are representative of at least three independent experiments,
unless otherwise stated. Statistical analysis was performed using two-tailed
Student unpaired t test, or Mann–Whitney or one-way ANOVA with Tukey
post hoc analysis were used as appropriate. Differences between variables
were considered statistically significant for p values ,0.05. The p values are
represented as follows: *p, 0.05, **p, 0.01, ***p, 0.001, ****p, 0.001.
Results
Adhesion to the ECM modulates MMP-1 gene expression and
secretion by M. tuberculosis–infected monocytes
Because MMP-1 is a key mediator of M. tuberculosis–associated
immunopathology (19), we investigated the role of components of
the ECM on the regulation of MMP-1 gene expression and se-
cretion by primary human monocytes in TB. The optimal coating
concentration for each ECM ligand was determined by titration in
an adhesion assay using a human monocyte cell line (Supplemental
Fig. 1A–C). M. tuberculosis–infected monocytes increased MMP-1
secretion after adhesion to collagen or fibronectin by 60% (from
1208.1 6 186 to 1934.4 6 135 pg/ml; p , 0.0001), and 63%
(1970.3 6 95 pg/ml; p , 0.001) respectively (Fig. 1A, 1B). Ad-
hesion to type IV collagen did not alter monocyte MMP-1 secretion
compared with cells cultured in the absence of ECM proteins
(Supplemental Fig. 1D). At the transcriptional level, MMP-1
mRNA accumulation in M. tuberculosis–stimulated human mono-
cytes increased 2.6-fold with adhesion to type I collagen, and 4.3-
fold with fibronectin (all p , 0.0001; Fig. 1C, 1D). Uninfected
monocytes were then stimulated with CoMtb to mimic the cytokine
networks between infected and uninfected cells that amplify MMP
expression within the granuloma. Stimulation with CoMCont was
used as control. MMP-1 secretion by CoMtb-stimulated uninfected
monocytes was also increased by adhesion to ECM substrates
(Supplemental Fig. 1E, 1F). Again, no significant difference in
MMP-1 concentrations was detected with monocyte adhesion to
type IV collagen (Supplemental Fig. 1G).
Next, we investigated the effect of the ECM on regulation on
other MMPs upregulated by stimulation with M. tuberculosis.
Infected monocytes secreted considerably higher concentrations
of the stromelysin MMP-10, which were increased by an addi-
tional 90% after adhesion to type I collagen (from 442.5 6 35 to
840 6 78 pg/ml; p , 0.0001; Fig. 1E) and by 55% with fibro-
nectin (686.2 6 44 pg/ml; p , 0.0001; Fig. 1F). MMP-3 secreted
concentrations were low, and no differences in secretion were seen
with adhesion to ECM proteins (Supplemental Fig. 2A, 2B). The
elastase MMP-7 was also upregulated following M. tuberculosis
infection and was further upregulated by 57% with type I collagen
(Fig. 1G, 1H). Secretion of MMP-2, a gelatinase, was downreg-
ulated in infected monocytes compared with uninfected controls
(p , 0.0001) but this was not affected by the ECM (Supplemental
Fig. 2C, 2D). The secretion of the other major gelatinase, MMP-9,
was upregulated by M. tuberculosis infection, but this too was not
affected by monocyte adhesion to ECM proteins (Supplemental
Fig. 2E, 2F).
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ECM and control of TIMP secretion in M. tuberculosis– and
CoMtb-stimulated monocytes
TIMPs are critical regulators of MMP activity and MMP:TIMP
ratios regulate net tissue destruction, and therefore secreted con-
centrations of TIMP-1 and -2 were also measured. M. tuberculosis
infection increased secretion of TIMP-1 by 2.6-fold (from 8.6 to
22.7 ng/ml; p, 0.0001; Fig. 2A), whereas TIMP-2 concentrations
decreased by ∼64% (Fig. 2B). However, the absolute TIMP-1
concentrations were much greater than the secreted TIMP-2
concentrations. Adhesion to type I collagen increased the TIMP-1
concentrations secreted by M. tuberculosis–stimulated monocytes
(from 22.71 6 8.86 to 27.69 6 8.78 ng/ml; p , 0.0001; Fig. 2A).
FIGURE 1. Secretion of MMP-1, -10, and -7
by M. tuberculosis–infected primary monocytes
is increased by adhesion to type I collagen and
fibronectin. Monocytes in the presence or ab-
sence of type I collagen, or fibronectin were
infected with M. tuberculosis (MOI = 1). For
secretion analysis, supernatants were collected at
24 h poststimulation, whereas for gene expres-
sion cell lysates were collected at 6 h. MMP-1
concentrations were upregulated in M. tubercu-
losis–infected monocytes adherent to (A) type I
collagen; (B) fibronectin, and MMP-1 mRNA
accumulation was also upregulated in the pres-
ence of (C) type I collagen and (D) fibronectin.
Samples were normalized to 18S rRNA. Secre-
tion of (E and F) MMP-10, and (G and H) MMP-7
was also upregulated in the presence of type I
collagen and fibronectin, after 24 h of M. tuber-
culosis infection. Graphs show means 6 SD and
are representative of three independent exper-
iments performed in triplicate. **p , 0.01,
***p , 0.001, ****p , 0.001. ns, not significant.
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Type I collagen did not affect TIMP-2 (Fig. 2B) and fibronec-
tin had no effect on the secretion of either TIMP-1 or -2 by
M. tuberculosis–stimulated monocytes (data not shown). CoMtb
stimulation similarly increased TIMP-1 and decreased TIMP-2
concentrations and secretion was not modulated by the ECM
(Fig. 2C, 2D).
Integrin expression by human monocytes in TB
Next, the surface expression of b1, b2, and b3 integrin subunits
was analyzed to investigate changes in integrin expression in
stimulated monocytes compared with controls and in the pres-
ence of the ECM (Fig. 3). MFIs for b1 integrin were similar in
all conditions, whereas for b2 there was only a small increase
with CoMtb stimulation compared with CoMCont. Surface
levels of b3 integrin were increased by CoMtb stimulation
(Fig. 3A).
Data in which b3 integrin expression in M. tuberculosis–
stimulated monocytes was normalized by subtracting basal
MFIs of the respective control showed that monocyte adhesion to
type I collagen and fibronectin increased integrin b3 MFIs by
3-fold (p , 0.05) (Fig. 3B). Because the only integrin heterodimer
expressed by primary human monocytes containing the b3 subunit
is the receptor aVb3, we next investigated the surface expression
of the aV subunit. M. tuberculosis–stimulated monocytes
adherent to type I collagen had significantly greater integrin
aV expression compared with cells cultured in the absence of
the ECM (p , 0.05; Fig. 3C). Adhesion to fibronectin also
significantly upregulated integrin aV expression compared with
M. tuberculosis–stimulated cells in the absence of the ECM
(p , 0.01; Fig. 3D). This was also investigated in CoMtb-
stimulated monocytes, and we found a similar increase in ex-
pression of b3 and aV integrin subunits with adhesion to type I
collagen, which was further increased by adhesion to ECM (p ,
0.05; Fig. 3D, 3E).
Integrin regulation of MMP secretion in TB
Next, the regulatory effect of integrin aVb3 activation on MMP-1
and MMP-10 gene expression and secretion by M. tuberculosis–
and CoMtb-stimulated monocytes was investigated. Integrin ac-
tivation was performed by precoating plates with anti-integrin Abs
to the ligand binding site to act as ligand mimetic. In M. tuber-
culosis–infected monocytes, activation of the b3 subunit caused
an 84% increase in monocyte MMP-1 secretion (from 1207 6 41
to 2218 6 253 pg/ml, p , 0.001; Fig. 4A), whereas no significant
differences were detected after activation of the b1 subunit, and a
small decrease in MMP-1 was detected with the b2 subunit (p ,
0.05). MMP-10 secretion was similarly upregulated by integrin b3
activation following M. tuberculosis infection (from 712.8 6 28.9
to 1115.96 86 pg/ml; Fig. 4B). A significant increase in MMP-10
concentrations was also detected after activation of b1 integrins.
Similar data were observed with CoMtb stimulation of human
monocytes following activation of the b3 integrin subunit (p ,
0.001; Fig. 4C, 4D). A small decrease in MMP-1 was also de-
tected with integrin b2 activation (from 11386 133 to 794.56 90
pg/ml). Monocyte MMP-10 secretion was not altered by activation
of b1 or b2 integrins in CoMtb-stimulated monocytes. Binding to
aV (which pairs with b3 on monocytes) resulted in a 13-fold in-
crease in MMP-1 secretion (p , 0.0001; Fig. 4E), and 14.7-fold in-
crease in MMP-10 concentrations (from 1459.736 36.9 to 21543.416
2485.7 pg/ml; p , 0.0001; Fig. 4F) following M. tuberculosis
infection. Binding to aValso increased MMP-1 and -10 secretion
from uninfected control monocytes.
Integrin b3 expression by cells extracted from sputum of
TB patients
Because integrin aVb3 was increased in our cellular model of
tuberculosis and its activation was associated with increased
MMP-1 and -10 secretion, we next investigated whether this might
be happening in TB patients. We investigated induced sputum
FIGURE 2. TIMP-1 and -2 secretion by
M. tuberculosis–infected and CoMtb-stimulated
monocytes adherent to type I collagen. Mono-
cytes adherent to type I collagen, fibronectin or
in the absence of matrix were either infected
with M. tuberculosis (MOI = 1) or stimulated
with CoMtb (1:5 dilution). Supernatants were
collected at 24 h postinfection and analyzed for
secreted concentrations of (A) TIMP-1 and (B)
TIMP-2 with M. tuberculosis–infected mono-
cytes, and (C) TIMP-1 and (D) TIMP-2 secretion
of CoMtb-stimulated monocytes. CoMCont was
used as control of CoMtb. Bars show mean 6
SD and data are representative of three inde-
pendent experiments performed in triplicate.
***p , 0.001, ****p , 0.001. ns, not significant.
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samples from a cohort of TB (n = 15) and control subjects (n = 11)
from Cape Town, South Africa (Fig. 5). This cohort of TB and
control subjects has been previously reported (29). Integrin b3
mRNA accumulation in patients with TB was increased by 78.6%
compared with control subjects when normalized to b-actin
mRNA (p , 0.05).
Integrin aVb3, collagen breakdown, and monocyte adhesion
and migration in TB
Next, confocal microscopy was used to analyze differences in
integrin aVb3 and MMP-1 localization in both uninfected control
monocytes (Fig. 6A–E) and M. tuberculosis–infected cells
(Fig. 6F–J). We observed increased integrin b3 staining with
FIGURE 3. Surface expression of b3 and aV integrin subunits in M. tuberculosis–stimulated monocytes adherent to ECM proteins. Monocytes cultured
in the presence or absence of type I collagen or fibronectin were stimulated for 24 h with CoMtb (1:5 dilution), and CoMCont as control, or directly infected
with M. tuberculosis (MOI = 1). Cells were fixed, blocked, and stained with FITC-conjugated anti-integrin b1or primary anti-integrin b2, b3, or aVAbs
and secondary FITC-conjugated anti-mouse IgG Ab. Secondary Ab alone or FITC-conjugated IgG1 isotype Ab were used as controls. (A) Histograms of
integrin subunits b1, b2, and b3 for control and CoMtb-stimulated monocytes show an increase in b3 expression with CoMtb stimulation. MFIs of integrin
subunits (B) b3 and (C) aV in monocytes stimulated with M. tuberculosis, and MFIs of (D) b3 and (E) aV in monocytes stimulated with CoMtb, in the
presence or absence of matrix components (n = 4). MFIs were normalized to baseline MFIs of respective controls (control media or CoMCont). (B)–(E)
show data points and means. *p , 0.05.
6 INTEGRIN REGULATION OF TISSUE DESTRUCTION IN TB
 by guest on July 10, 2017
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
M. tuberculosis infection compared with controls (Fig. 6C, 6H).
MMP-1 expression was also markedly increased with M. tuber-
culosis infection (Fig. 6D, 6I) and there was colocalization of
integrin aVb3 with MMP-1 in infected monocytes (white stain-
ing, Fig. 6J).
To investigate the functional consequences of integrin aVb3
binding, which resulted in increased MMP-1 secretion, DQ
collagen–coated slides were used to analyze type I collagen
breakdown. Increased DQ collagen fluorescence, which corre-
sponds to areas of collagen breakdown, was markedly increased
with M. tuberculosis infection, compared with uninfected controls,
but when integrin b3 was inhibited by 20 mg/ml anti-integrin
b3 Abs, collagen breakdown decreased, as well as the number
of cells adherent to the collagen-coated slide, which further
implicates integrin aVb3 on regulation of MMP-1 activity in
TB (Fig. 7A). To analyze integrin aVb3–mediated monocyte
adhesion to type I collagen in TB, monocytes labeled with
CellTracker Green dye were seeded in either type I collagen-
coated or uncoated wells prior CoMtb or CoMCont stimulation.
Monocyte adhesion was significantly increased with CoMtb
stimulation (p , 0.001, Fig. 7B) and was higher in the presence
of type I collagen. Inhibition of integrin b3 activity with
blocking Abs markedly decreased cell adhesion with CoMtb
stimulation. Next, transwell assays were performed to ana-
lyze integrin aVb3 involvement in monocyte migration in TB.
With CoMtb stimulation, the number of transmigrated mono-
cytes was 2.2-fold higher than in CoMCont controls (p ,
0.0001; Fig. 7C). However, blockade of either b3 or aV
integrin subunits led to a dramatic 96 and 92% decrease in
monocyte transmigration respectively (both p , 0.0001),
demonstrating a key role in monocyte migration. No change
in monocyte migration was seen with blockade of b1 integrins
(Supplemental Fig. 3).
FIGURE 4. Regulation of MMP-1 and -10 by
integrin b and aV subunits in M. tuberculosis–
infected and CoMtb-stimulated primary mono-
cytes. Plates were precoated with goat anti-mouse
Fc region, blocked, and coated with 20 mg/ml
either mouse anti-human integrin b1, b2, b3
Abs, or left uncoated and stimulated for 24 h
with (A and B) M. tuberculosis or (C and D)
CoMtb. CoMCont was used as control for
CoMtb. Supernatants were collected and
assayed for MMP-1 and MMP-10. Plates were
also coated with 20 mg/ml anti-integrin aV Abs,
monocytes infected with M. tuberculosis (MOI = 1)
and supernatants assayed for (E) MMP-1 and
(F) MMP-10. Graphs show means 6 SD and
are representative of three independent experi-
ments performed in triplicate. *p , 0.05, ***p ,
0.001, ****p , 0.0001.
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Discussion
In this study, to our knowledge we demonstrate for the first time in
M. tuberculosis infection that human monocyte adhesion to type I
collagen and fibronectin, which are key in the lung matrix, sig-
nificantly increase MMP-1, -7, and -10 gene expression and se-
cretion, and that this is regulated via activation of integrin aVb3
on monocytes and in TB patients. In contrast, the gelatinases
MMP-2 and -9, which are also secreted in response to TB, were
not affected by monocyte binding to ECM.
We show that type I collagen and fibronectin increase MMP-1
gene expression and secretion by monocytes after direct
M. tuberculosis infection as well as in response to CoMtb, which
mimics in vivo M. tuberculosis–dependent signaling networks
between infected and uninfected cells. However, type IV col-
lagen, found in basement membranes, did not induce a similar
effect, which indicates that this response is ligand specific.
Monocyte-derived MMP-10 was also upregulated by adhesion
to type I collagen and fibronectin. Although stromelysins are
not able to degrade type I collagen, they are functionally im-
portant in TB because they may activate collagenases such as
MMP-1. MMP-3 is secreted at low concentrations by M. tu-
berculosis–infected monocytes, and is therefore less critical
than MMP-10. In contrast, gelatinase secretion was not af-
fected by binding to the ECM. Type I collagen had minimal
effects on TIMP-1 secretion, which is increased by M. tuber-
culosis stimulation, or on TIMP-2 secretion, which was de-
creased by TB.
In dissecting the mechanisms by which the lung matrix in-
creased MMP-1 and -10 secretion, we observed that M. tu-
berculosis infection was associated with increased surface
expression of the integrin b3 subunit. There were no significant
differences in expression of the integrin subunits b1 and b2 in
infected monocytes, although they do have other immunological
functions in TB (30, 31). CoMtb stimulation of monocytes in-
creased aVb3 surface expression, which rose further in the
presence of type I collagen. Activation of aVb3 integrin resulted
in increased expression of MMP-1 and -10. This is consistent
with a murine study showing that overexpression of avb3 in
breast cancer cells increased the formation of osteolytic lesions,
indicating a role for this integrin in driving tissue damage (32).
Although not directly involved in adhesion to native type I col-
lagen in healthy tissues, in inflammation RGD-binding motifs
within the collagen fibrils become exposed, allowing adhesion of
aVb3 (33, 34), which provides a positive feedback loop for
MMP-1 and -10 expression. This is consistent with our observation
that inhibition of integrin aVb3 in M. tuberculosis–stimulated
monocytes led to decreased type I collagen breakdown and de-
creased monocyte adhesion. These findings are potentially clinically
important in TB patients because to our knowledge we have dem-
onstrated for the first time that the b3 subunit was upregulated in
induced sputum of patients with active TB compared with control
subjects.
Importantly, integrin aVb3 was specifically required for
monocyte migration and blockade of either aV or b3 subunits
dramatically impaired migration in a transwell system. In the
zebrafish model of TB, macrophage migration was central to the
dissemination of infection to new sites in an MMP-9–dependent
manner (35), and excessive leukocyte migration may lead to ad-
verse effects in TB, including tissue damage (28). Confocal mi-
croscopy revealed integrin aVb3 microclustering and areas of
FIGURE 5. Integrin b3 mRNA is increased in cells from sputum sam-
ples of TB patients. Induced sputum samples were collected prospectively
from patients with active pulmonary TB (n = 15) and control subjects (n = 11)
in Cape Town. Integrin b3 mRNA accumulation was analyzed by real-time
RT-PCR, and b-actin mRNA was used as the control gene. Horizontal lines
represent median values. Statistical analysis was performed using a Mann–
Whitney U test (*p , 0.05).
FIGURE 6. Integrin b3 colocalizes with MMP-1 in M. tuberculosis infection. Monocytes seeded in collagen-coated chamber slides were infected with
M. tuberculosis (MOI = 1). Cells were fixed, blocked, and stained with DAPI for nucleic acids (blue), integrin aVb3 (green), and MMP-1 (magenta). (A)
and (F) show brightfield and (B)–(D) show fluorescence of control monocytes and (G–I) fluorescence ofM. tuberculosis–infected monocytes. (E) and (J) are
merged fluorescence images. White color corresponds to areas of integrin and MMP colocalization. Scale bar, 25 mm.
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colocalization between integrin aVb3 and MMP-1, which
tended to localize at monocyte protrusions, consistent with trailing
uropods of migrating monocyte or areas of monocyte-monocyte
adhesion.
Taken together the present work shows that, in M. tuberculosis–
infected monocytes, increased integrin aVb3 expression, which is
also found in TB patients, promotes increased monocyte adhesion
to ECM, and upregulates MMP-1 and -10 secretion, which in turn
will drive ECM breakdown. The ECM thereby regulates enzymes
required for the influx of inflammatory monocytes, which are also
involved in driving tissue damage leading to morbidity and mor-
tality in TB. Leukocyte-ECM interactions are potential targets to
develop host-directed therapy aimed at reducing the inflamma-
tion and matrix degradation that characterize infection with
M. tuberculosis.
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